老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Iovance Biotherapeutics, Inc.

4.11
+0.410011.08%
盘后：4.06-0.0499-1.21%19:59 EDT
成交量：2,310.11万
成交额：9,381.26万
市值：18.35亿
市盈率：-4.43
高：4.20
开：3.70
低：3.69
收：3.70
52周最高：5.63
52周最低：1.66
股本：4.47亿
流通股本：3.88亿
量比：2.50
换手率：5.95%
股息：- -
股息率：- -
每股收益(TTM):-0.9281
每股收益(LYR):-1.0941
净资产收益率：-47.51%
总资产收益率：-23.65%
市净率：2.54
市盈率(LYR):-3.76

数据加载中...

总览公司新闻资讯公告
2020/08/06

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/06

重要事件披露

8-K - Current report
2020/06/19

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/06/19

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/06/12

重要事件披露

8-K - Current report
2020/06/09

重要事件披露

8-K - Current report
2020/06/02

重要事件披露

8-K - Current report
2020/05/29

重要事件披露

8-K - Current report
2020/05/27

重要事件披露

8-K - Current report
2020/05/22

重要事件披露

8-K - Current report
2020/05/08

重要事件披露

Current report, items 8.01 and 9.01
2020/05/05

季度报告

Quarterly report [Sections 13 or 15(d)]
2020/05/05

重要事件披露

Current report, items 2.02 and 9.01
2020/02/25

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/25

重要事件披露

Current report, items 2.02 and 9.01
2020/02/24

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/11

超过5%披露

Statement of acquisition of beneficial ownership by individuals
更多